PLUME BIOTECHNOLOGY LIMITED

Active United Kingdom

Research and experimental development on biotechnology

5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PLUME BIOTECHNOLOGY LIMITED

Research and experimental development on biotechnology

Founded 17 May 2021 Active United Kingdom 5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 13 Jan 2026 Next due 28 Feb 2027 8 months remaining
Confirmation Submitted 19 May 2026 Next due 30 May 2027 11 months remaining
Net assets £-751K £381K 2025 year on year
Total assets £544K £250K 2025 year on year
Total Liabilities £1M £631K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for PLUME BIOTECHNOLOGY LIMITED (13404705), an active life sciences and medical technology company based in United Kingdom. Incorporated 17 May 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jun → 31 May 2025
Type micro-entity
Next accounts 31 May 2026
Due by 28 Feb 2027 8 months remaining

Net Assets, Total Assets & Total Liabilities (2022–2025)

Cash in Bank

N/A

Net Assets

-£751.40k

Decreased by £380.93k (-103%)

Total Liabilities

£1.30M

Increased by £630.73k (+95%)

Turnover

N/A

Employees

5

Increased by 2 (+67%)

Debt Ratio

238%

Increased by 12 (+5%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 May Year End
2024
31 May Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 555 Shares £300k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
19 May 2023555£300k£540.054

Officers

Officers

3 active
Status
Burns, Thomas James, DrDirectorBritishEngland3517 May 2021Active
Chandler, Emma, DrDirectorBritishEngland3217 May 2021Active
James McgoldrickSecretaryUnknownUnknown13 May 2025Active

Shareholders

Shareholders (4)

Thomas Burns
37.5%
395,600
Emma Chandler
28.8%
304,300

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Emma Chandler

British

Active
Notified 18 May 2023
Residence England
DOB April 1994
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Thomas James Burns

British

Active
Notified 18 May 2023
Residence England
DOB November 1990
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 May 2026Confirmation StatementConfirmation statement made on 16 May 2026 with updates
13 Jan 2026AccountsAnnual accounts made up to 31 May 2025
20 Oct 2025CapitalCapital Alter Shares Subdivision
9 Jun 2025Confirmation StatementConfirmation statement made on 16 May 2025 with no updates
9 Jun 2025OfficersTermination of Ross Alexander Mcmaster as director on 13 May 2025
19 May 2026 Confirmation Statement

Confirmation statement made on 16 May 2026 with updates

13 Jan 2026 Accounts

Annual accounts made up to 31 May 2025

20 Oct 2025 Capital

Capital Alter Shares Subdivision

9 Jun 2025 Confirmation Statement

Confirmation statement made on 16 May 2025 with no updates

9 Jun 2025 Officers

Termination of Ross Alexander Mcmaster as director on 13 May 2025

Recent Activity

Latest Activity

Confirmation statement made on 16 May 2026 with updates

2 weeks ago on 19 May 2026

Annual accounts made up to 31 May 2025

4 months ago on 13 Jan 2026

Capital Alter Shares Subdivision

7 months ago on 20 Oct 2025

Confirmation statement made on 16 May 2025 with no updates

12 months ago on 9 Jun 2025

Termination of Ross Alexander Mcmaster as director on 13 May 2025

12 months ago on 9 Jun 2025